Emotional Regulation, Impulsivity in Cannabis Its Relation to MRI Brain Structure

Sponsor
Assiut University (Other)
Overall Status
Completed
CT.gov ID
NCT03483220
Collaborator
(none)
66
1
9.7
6.8

Study Details

Study Description

Brief Summary

cannabis addiction is a major health hazard that has its effect on personality and behavior including the impulsivity and emotional regulation. It also has its effect on both the structure and function of different brain regions involved in brain reward system.

the aim of the study is to study the emotional regulation and impulsivity among people with cannabis addiction studying the change in the volume of brain reward system structures' volume in relation to cannabis addiction and the change in the mentioned behavioral traits.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: MRI brain

Detailed Description

Introduction:

Cannabis sativa is a widely used drug comprising a broad spectrum of usage ranging from recreational users to chronic addicts.

Dependence on cannabis is considered a major global health related issue. Cannabis is still considered the most used psychoactive substance worldwide with an estimated 2.8-5.1 % of global adult population has used cannabis in 2019.

Epidemiological studies show that cannabis is the leading drug of abuse in Egypt and in Upper Egypt. Prevalence of cannabis dependence is estimated to be 7.4% in Egypt and 6.66 % in Upper Egypt.

Cannabis dependence is associated with multiple neurobehavioral abnormalities which can be considered as a psychological determinants of cannabis dependence .

There is an increasing evidence of association between emotional dysregulation and dependence on different substances of abuse. Such dysregulation affects both components of emotional regulation; reappraisal and suppression of emotions' expression. The pattern of this dysregulation differs according to the type of substance of dependence and can affect the pattern of substance abuse.

Impulsivity is a proposed endophenotype for substance dependence as well as a possible consequence of prolonged drug use. Drugs of addiction and subconscious craving are likely to increase impulsiveness due to the loss of frontal cortical inhibition of impulses and increased limbic drive. Cannabis use may lead to a loss of attention, reflection and inhibitory control.

Materials and Methods:

This cross-sectional study ran between at the addiction management unit, Assiut University, Egypt. Two groups of participants were recruited in the study: Group (A): 32 patients with cannabis used disorder diagnosed according to DSM-5 criteria recruited from the addiction outpatient clinic at the Hospital of Neurology and Psychiatry at Assiut University. Group (B): 34 healthy individuals as a cross matching control group.

Inclusion criteria were age above 18 years, current chronic cannabis dependence. Exclusion criteria were being in withdrawal state, other psychiatric disorders, and history or current neurological or medical disease.

Ethical considerations:

A signed, informed consent was obtained from patients and their families or caregivers to participate in the study. Confidentiality was maintained during the whole study.

Assessment tools:

All participants were first assessed through a semi-structured interview using the Structured clinical interviews for axis I diagnosis (SCID-I) to rule out any psychiatric comorbidities.

Emotion Regulation Questionnaire (ERQ): A 10-item scale designed to measure respondents' tendency to regulate their emotions in two ways: (1) Cognitive Reappraisal and (2) Expressive Suppression. Respondents answer each item on a 7-point Likert-type scale.

UPPS-P Impulsive Behavior Scale- Short form: The UPPS-P impulsivity scale is a 20-item scale designed to assess five distinct personality traits to impulsive behavior: Negative Urgency, Lack of Perseverance, Lack of Premeditation, Positive Urgency and Sensation Seeking.

Magnetic resonance imaging examination:

The MR examination of brain was done using 1.5T MR scanner (Achieva, Philips Medical Systems, The Netherlands) with a 16 channel head coil without using any sedation.

Study Design

Study Type:
Observational
Actual Enrollment :
66 participants
Observational Model:
Cohort
Time Perspective:
Cross-Sectional
Official Title:
Relation Between Emotional Regulation and Impulsivity in Cannabis Use Disorder and the Morphometric Changes in Brain Reward System Structures
Actual Study Start Date :
Mar 1, 2021
Actual Primary Completion Date :
Sep 30, 2021
Actual Study Completion Date :
Dec 20, 2021

Arms and Interventions

Arm Intervention/Treatment
cases

patients with cannabis use disorder

Diagnostic Test: MRI brain
1. Emotion Regulation Questionnaire (ERQ): A 10-item scale designed to measure respondents' tendency to regulate their emotions in two ways: (1) Cognitive Reappraisal and (2) Expressive Suppression. Respondents answer each item on a 7-point Likert-type scale . UPPS-P Impulsive Behavior Scale- Short form: The UPPS-P impulsivity scale is a 20-item scale designed to assess five distinct personality traits to impulsive behavior: Negative Urgency, Lack of Perseverance, Lack of Premeditation, Positive Urgency and Sensation Seeking . Magnetic resonance imaging examination: The MR examination of brain was done using 1.5T MR scanner (Achieva, Philips Medical Systems, The Netherlands) with a 16 channel head coil without using any sedation.
Other Names:
  • Emotion Regulation Questionnaire (ERQ)
  • UPPS-P Impulsive Behavior Scale
  • structured clinical interview
  • Outcome Measures

    Primary Outcome Measures

    1. degree of impulsivity in addicts [7 months]

      the UPPS-P scale was used to measure the degree of impulsivity. it is a 20-item scale designed to assess five distinct personality traits to impulsive behavior: Negative Urgency, Lack of Perseverance, Lack of Premeditation, Positive Urgency and Sensation Seeking

    2. measuring the volume of prefrontal cortex in addicts [7 months]

      MRI brain with voxel based morphometry was used in measuring the volume of different brain regions involved in the brain reward system

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 45 Years
    Sexes Eligible for Study:
    Male
    Inclusion Criteria:
    • Age above 18 years.

    • Clearly consenting to participate in the study. . patient with substance use disorder

    Exclusion Criteria:
    • Intoxication or withdrawal state.

    • Comorbid Axis I psychiatric disorder.

    • any current or past neurological disorder.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Assiut University Assiut Egypt 71111

    Sponsors and Collaborators

    • Assiut University

    Investigators

    • Study Chair: Khaled AM Elbeh, professor, Assiut University
    • Study Director: Yasser M Elsorogy, professor, Assiut University
    • Study Director: Gilan K Ramadan, Lecturer, Assiut University
    • Study Director: Gehan S Seif, professor, Assiut University

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    Sayed Mostafa, Lecturer of psychiatry, Assiut University
    ClinicalTrials.gov Identifier:
    NCT03483220
    Other Study ID Numbers:
    • MRI brain study in addiction
    First Posted:
    Mar 30, 2018
    Last Update Posted:
    Jan 25, 2022
    Last Verified:
    Jan 1, 2022
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Sayed Mostafa, Lecturer of psychiatry, Assiut University
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 25, 2022